Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin
The FDA ultimately ruled against approving leucovorin for autism, citing a lack of “sufficient data.”
Source: www.gizmodo.com
Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin
The FDA ultimately ruled against approving leucovorin for autism, citing a lack of “sufficient data.”
Source: www.gizmodo.com
